0001061983-13-000012.txt : 20130307
0001061983-13-000012.hdr.sgml : 20130307
20130307184506
ACCESSION NUMBER: 0001061983-13-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130305
FILED AS OF DATE: 20130307
DATE AS OF CHANGE: 20130307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WOLFF ANDREW A
CENTRAL INDEX KEY: 0001238406
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 13674857
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-03-05
0
0001061983
CYTOKINETICS INC
CYTK
0001238406
WOLFF ANDREW A
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP Clinical R&D, CMO
Common Stock
67948
D
Incentive Stock Option (right to buy)
1
2013-03-05
4
A
0
119103
0
A
2013-04-05
2023-03-05
Common Stock
119103
119103
D
Non-Qualified Stock Option (right to buy)
1
2013-03-05
4
A
0
130897
0
A
2013-04-05
2023-03-05
Common Stock
130897
130897
D
Incentive Stock Option (right to buy)
1.05
2012-04-05
2022-03-05
Common Stock
58665
58665
D
Incentive Stock Option (right to buy)
1.57
2011-03-31
2021-02-28
Common Stock
58336
58336
D
Incentive Stock Option (right to buy)
1.85
2009-03-26
2019-02-26
Common Stock
37917
37917
D
Incentive Stock Option (right to buy)
3.08
2010-03-24
2020-02-24
Common Stock
42084
42084
D
Incentive Stock Option (right to buy)
3.37
2008-03-29
2018-02-28
Common Stock
27935
27935
D
Incentive Stock Option (right to buy)
6.59
2005-04-11
2015-04-11
Common Stock
781
781
D
Incentive Stock Option (right to buy)
6.81
2007-04-01
2017-03-14
Common Stock
14185
14185
D
Incentive Stock Option (right to buy)
7.15
2006-03-01
2016-03-01
Common Stock
17019
17019
D
Incentive Stock Option (right to buy)
9.91
2005-09-20
2014-10-20
Common Stock
40360
40360
D
Non-Qualified Stock Option (right to buy)
1.05
2012-04-05
2022-03-05
Common Stock
116335
116335
D
Non-Qualified Stock Option (right to buy)
1.57
2011-03-31
2021-02-28
Common Stock
141664
141664
D
Non-Qualified Stock Option (right to buy)
1.85
2009-03-26
2019-02-26
Common Stock
92083
92083
D
Non-Qualified Stock Option (right to buy)
3.08
2010-03-24
2020-02-24
Common Stock
92916
92916
D
Non-Qualified Stock Option (right to buy)
3.37
2008-03-29
2018-02-28
Common Stock
97065
97065
D
Non-Qualified Stock Option (right to buy)
6.59
2005-04-11
2015-04-11
Common Stock
11719
11719
D
Non-Qualified Stock Option (right to buy)
6.81
2007-04-01
2017-03-14
Common Stock
40815
40815
D
Non-Qualified Stock Option (right to buy)
7.15
2006-03-01
2016-03-01
Common Stock
42981
42981
D
Non-Qualified Stock Option (right to buy)
9.91
2005-09-20
2014-10-20
Common Stock
69640
69640
D
Restricted Stock Units
Common Stock
87500
87500
D
When the ISO and NQ dated 03/05/2013 are combined for a total grant of 250,000 shares, the option shall vest and become exercisable as to 250,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/05/2017.
When the ISO and NQ dated 03/05/2012 are combined for a total grant of 175,000 shares, the option shall vest and become exercisable as to 3,645 shares on 04/05/2012 and the balance of 171,355 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/05/2016.
When the ISO and NQ dated 02/28/2011 are combined for a total grant of 200,000 shares, the option shall vest and become exercisable as to 4,166 shares on 03/31/2011 and the balance of 195,834 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015.
When the ISO and NQ dated 02/26/2009 are combined for a total grant of 130,000 shares, the option shall vest and become exercisable as to 2,708 shares on 03/26/09 and the balance of 127,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
When the ISO and NQ dated 02/24/2010 are combined for a total grant of 135,000 shares, the option shall vest and become exercisable as to 2,812 shares on 03/24/2010 and the balance of 132,188 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014.
When the ISO and NQ dated 02/29/2008 are combined for a total grant of 125,000 shares, the option shall vest and become exercisable as to 2,604 shares on 03/29/08 and the balance of 122,396 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
When the ISO and NQ dated 04/11/05 are combined for a total grant of 12,500 shares, the option shall vest and become exercisable as to 12,500 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009.
When the ISO and NQ dated 03/14/2007 are combined for a total grant of 55,000 shares, the option shall vest and become exercisable as to 1,146 shares on 04/01/07 and the balance of 53,854 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010.
When the ISO and NQ dated 10/20/04 are combined for a total grant of 110,000 shares, the option shall vest and become exercisable as to 27,500 shares on 09/20/05 and the balance of 82,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 09/20/08.
Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock.
The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.
Andrew A. Wolff, M.D.
2013-03-07